(Q33420969)

English

The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

amoxicillin/clavulanic acid

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

A Kuss

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

F Berrisoul

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

N Kearsley

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A Torres

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

R Kubin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 April 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Respiratory Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

93

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

252-261

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10464889%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Epidemiology and treatment of chronic bronchitis and its exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentin in acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of Miraxid (pivmecillinam plus pivampicillin) and Augmentin (amoxycillin plus clavulanic acid) in the treatment of lower respiratory tract infections in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative clinical and microbiological study of amoxycillin-clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower respiratory tract infection therapy--the role of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990021-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33420969&oldid=1981141561"